Issue 9/2013
Content (23 Articles)
In memoriam: Ludwig G. Strauss, MD, 1949–2013
Antonia Dimitrakopoulou-Strauss, Ignasi Carrió
PET/CT and breast cancer subtypes
Laura Gilardi, Marco Colleoni, Giovanni Paganelli
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT
Ana María García Vicente, Ángel Soriano Castrejón, Alberto León Martín, Ignacio Chacón López-Muñiz, Vicente Muñoz Madero, María del Mar Muñoz Sánchez, Azahara Palomar Muñoz, Ruth Espinosa Aunión, Ana González Ageitos
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, Alberto Biggi, Amanda F. Cashen, Pierre Véra, Hervé Tilly, Barry A. Siegel, Andrea Gallamini, René-Olivier Casasnovas, Corinne Haioun
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma
Choon-Young Kim, Chae Moon Hong, Do-Hoon Kim, Seung Hyun Son, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, Byeong-Cheol Ahn
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma
Raghava Kashyap, Eddie Lau, Anupkumar George, John F. Seymour, Stephen Lade, Rodney J. Hicks, Michael S. Hofman
Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CT
Yasuka Kikuchi, Noriko Oyama-Manabe, Osamu Manabe, Masanao Naya, Yoichi M. Ito, Kanako C. Hatanaka, Hiroyuki Tsutsui, Satoshi Terae, Nagara Tamaki, Hiroki Shirato
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)
Odré Palie, Pierre Michel, Jean-François Ménard, Caroline Rousseau, Emmanuel Rio, Boumédiene Bridji, Ahmed Benyoucef, Marc-Etienne Meyer, Khadija Jalali, Stéphane Bardet, Che Mabubu M’Vondo, Pierre Olivier, Guillaume Faure, Emmanuel Itti, Christian Diana, Claire Houzard, Françoise Mornex, Frederic Di Fiore, Pierre Vera
Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
Sotirios Chondrogiannis, Maria Cristina Marzola, Alice Ferretti, Anna Margherita Maffione, Lucia Rampin, Gaia Grassetto, Cristina Nanni, Patrick M. Colletti, Domenico Rubello
68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma
Volker H. Schartinger, József Dudás, Clemens Decristoforo, Christoph Url, Johannes Schnabl, Georg Göbel, Irene J. Virgolini, Herbert Riechelmann, Michael Rasse, Dietmar Waitz, Daniel Putzer
Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?
Caroline Rousseau, Françoise Kraeber-Bodéré, Jacques Barbet, Jean-François Chatal
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody
Catharina M. van Rij, Susanne Lütje, Cathelijne Frielink, Robert M. Sharkey, David M. Goldenberg, Gerben M. Franssen, William J. McBride, Edmund A. Rossi, Wim J. G. Oyen, Otto C. Boerman
Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
Jorge A. Carrasquillo, Joseph A. O’Donoghue, Neeta Pandit-Taskar, John L. Humm, Dana E. Rathkopf, Susan F. Slovin, Matthew J. Williamson, Kristine Lacuna, Anne-Kirsti Aksnes, Steven M. Larson, Howard I. Scher, Michael J. Morris
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia
Javier Arbizu, E. Prieto, P. Martínez-Lage, J. M. Martí-Climent, M. García-Granero, I. Lamet, P. Pastor, M. Riverol, M. T. Gómez-Isla, I. Peñuelas, J. A. Richter, M. W. Weiner
[11C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches
Zhangjie Su, Karl Herholz, Alexander Gerhard, Federico Roncaroli, Daniel Du Plessis, Alan Jackson, Federico Turkheimer, Rainer Hinz
18F-FDG PET/CT in HIV-related central nervous system pathology
Scarlett Lewitschnig, Keerti Gedela, Martina Toby, Ranjababu Kulasegaram, Mark Nelson, Michael O’Doherty, Gary J. R. Cook
Perfusion SPECT in patients with suspected pulmonary embolism
Marika Bajc, Massimo Miniati, Jonas Jögi, Paul D. Stein
Highlights of the 25th Anniversary EANM Congress Milan 2012: nuclear medicine and molecular imaging at its best
Werner Langsteger, Mohsen Beheshti
RETRACTED ARTICLE: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging
Benjamin Jacob Hayempour, Abass Alavi
Reply to: Area under the cumulative SUV-volume histogram is not a viable metric of intratumoral metabolic heterogeneity
Floris H. P. van Velden, Ronald Boellaard
The value of renal scintigraphy in the diagnosis of intrarenal urinoma
Hamid Javadi, Majid Assadi